In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Vaccitech Plc (VACC – Research Report), with a price target of $23.00. The company's shares closed last Wednesday at $5.20, close to its 52-week low of $4.47. According to TipRanks.com, Chen is a 3-star analyst with an average return of 3.9% and a 36.4% success rate. Chen covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Vaccitech Plc with a $23.00 average price target, implying a 349.
https://www.tipranks.com/news/blurbs/vaccitech-plc-vacc-gets-a-buy-rating-from-h-c-wainwright-2?utm_source=advfn.com&utm_medium=referral
Vaccitech (NASDAQ:VACC)
Historical Stock Chart
From May 2022 to Jun 2022 Click Here for more Vaccitech Charts.
Vaccitech (NASDAQ:VACC)
Historical Stock Chart
From Jun 2021 to Jun 2022 Click Here for more Vaccitech Charts.